Jeremy T Moskovitch1, Peter F Mount1,2,3, Matthew R P Davies1,2. 1. Department of Medicine, The University of Melbourne, Melbourne, Australia. 2. Nephrology Department, Austin Health, Melbourne, Australia. 3. Kidney Laboratory, Institute of Breathing and Health, Austin Health, Heidelberg, Australia.
Abstract
INTRODUCTION: To determine the prevalence, severity, and change in symptoms experienced by dialysis patients following the introduction of use of a symptom-reporting questionnaire in nephrology clinic. METHODS: This is an observational study of 160 prevalent dialysis patients. Palliative care Outcome Scale symptom (POS-renal) questionnaires modified for patients with end-stage kidney disease were completed at baseline and follow-up (median 3 months), with results available to nephrologists at clinic appointments. FINDINGS: The baseline prevalence of individual symptoms ranged from 15% to 66%. The most common symptoms were lack of energy (66%) and poor mobility (58%). The median number of symptoms was 7/17 (interquartile range [IQR]: 4-10). Forty-nine percent of patients rated at least 1 symptom as severe or overwhelming. At follow-up, the median number of symptoms experienced was unchanged at 7/17 (IQR: 3-10). However, there was considerable flux in symptom severity. On average, individual symptoms that were present at baseline improved in 56% of patients and worsened in 18%; only 26% had stable symptom severity. Individual symptoms newly occurred in 8% to 20% of patients between time points, with 77% of patients experiencing at least 1 new symptom. The percent of patients rating at least 1 symptom as severe or overwhelming was reduced from 49% to 39% (P = .040). CONCLUSIONS: Use of the POS-renal questionnaire identified a high symptom burden. The presence and severity of symptoms changed dramatically over a short follow-up period, highlighting the need for regular surveillance of symptoms in the dialysis population. Routine use of a symptom questionnaire in clinic may be useful for the identification and management of symptoms in dialysis patients.
INTRODUCTION: To determine the prevalence, severity, and change in symptoms experienced by dialysis patients following the introduction of use of a symptom-reporting questionnaire in nephrology clinic. METHODS: This is an observational study of 160 prevalent dialysis patients. Palliative care Outcome Scale symptom (POS-renal) questionnaires modified for patients with end-stage kidney disease were completed at baseline and follow-up (median 3 months), with results available to nephrologists at clinic appointments. FINDINGS: The baseline prevalence of individual symptoms ranged from 15% to 66%. The most common symptoms were lack of energy (66%) and poor mobility (58%). The median number of symptoms was 7/17 (interquartile range [IQR]: 4-10). Forty-nine percent of patients rated at least 1 symptom as severe or overwhelming. At follow-up, the median number of symptoms experienced was unchanged at 7/17 (IQR: 3-10). However, there was considerable flux in symptom severity. On average, individual symptoms that were present at baseline improved in 56% of patients and worsened in 18%; only 26% had stable symptom severity. Individual symptoms newly occurred in 8% to 20% of patients between time points, with 77% of patients experiencing at least 1 new symptom. The percent of patients rating at least 1 symptom as severe or overwhelming was reduced from 49% to 39% (P = .040). CONCLUSIONS: Use of the POS-renal questionnaire identified a high symptom burden. The presence and severity of symptoms changed dramatically over a short follow-up period, highlighting the need for regular surveillance of symptoms in the dialysis population. Routine use of a symptom questionnaire in clinic may be useful for the identification and management of symptoms in dialysis patients.
Authors: Thalwaththe Gedara Nadeeka Shayamalie Gunarathne; Li Yoong Tang; Soo Kun Lim; Nishantha Nanayakkara; Hewaratne Dassanayakege Wimala Thushari Damayanthi; Khatijah L Abdullah Journal: Int J Environ Res Public Health Date: 2022-05-03 Impact factor: 4.614
Authors: Katharine L Cheung; Samantha Smoger; Manjula Kurella Tamura; Renee D Stapleton; Terry Rabinowitz; Michael A LaMantia; Robert Gramling Journal: J Palliat Med Date: 2022-03-04 Impact factor: 2.947
Authors: Jonathan Gale; David Austin Clark; Clara Bohm; Mark Canney; Ian Davis; Jason Joseph LeBlanc; Angela Maxine Shorter; Rita S Suri; Amanda Jean Vinson; Kenneth A West; Karthik Kannan Tennankore Journal: Can J Kidney Health Dis Date: 2020-10-14
Authors: Pann Ei Hnynn Si; Rachel Gair; Tania Barnes; Louese Dunn; Sonia Lee; Steven Ariss; Stephen J Walters; Martin Wilkie; James Fotheringham Journal: PLoS One Date: 2022-09-27 Impact factor: 3.752